With a compounded medicine, the storage instructions need to match the preparation in your hands. A general sermorelin page cannot establish how long every vial may be kept, which temperatures it tolerates, or what changes after mixing or first use.
Ask the dispensing pharmacist to explain the label before you need to manage a delay or a trip. Keep the contact information, written directions, and original packaging available so you can describe exactly what happened if something goes wrong.
Use product-specific instructions. Do not borrow a temperature window from another medicine.
Separate unopened, prepared, and in-use instructions
Different preparation states can have different requirements. Ask which directions apply to the medicine as shipped and which apply after any required preparation or first use. Confirm the beyond-use information instead of assuming a general expiration rule.
If mixing is required, obtain instructions for that prescription and the specified supplies. Do not calculate a new recipe from a social post. The pharmacy guide explains why concentration, quantity, and directions need to be interpreted separately.
Ask what to do when a shipment is delayed
Record the delivery timing and any visible problem with the package, label, or container. Contact the pharmacy about the exposure you can describe rather than deciding that the medicine is usable because it looks clear or feels cool now.
FDA's temperature guidance supports seeking advice about medicines exposed to unsuitable conditions. It does not establish one universal sermorelin allowance. Ask whether the preparation should be held while the pharmacist investigates and how a replacement question is handled.
Plan refrigeration around real life
Ask where the medicine should be kept, how to protect it from freezing, and what to do during a power interruption. Do not assume the coldest part of a refrigerator is necessarily the right place for the preparation.
Keep it identifiable and inaccessible to children or anyone for whom it was not prescribed. If more than one injectable medicine is stored together, retain the labels and ask the pharmacist about avoiding mix-ups. Clear organization is useful; transferring medicine to an unlabeled container is not.
Discuss a trip before the day you leave
Travel introduces several different questions: suitable storage, access to clinical support, the appointment location, and the rules for carrying medicine. Ask the pharmacist how the actual preparation can be transported and the prescriber how interruptions should be managed.
If a remote follow-up happens while you are away, tell the practice where you will physically be. HHS explains that state licensing pathways matter. Our location directory helps orient the search but does not authorize a consultation or establish destination entry rules.
Do not improvise after a problem
A missed delivery, unclear label, or questionable temperature history is a reason to contact the relevant professional. Do not double an amount, substitute another product, or keep using a preparation simply to avoid wasting a purchase.
Ask the clinician and pharmacy to agree on the next step. Our safety guide addresses symptom questions, while the cost guide covers financial commitments. Those are connected practical concerns, but a refund discussion cannot determine whether a medicine remains appropriate to use.
Follow the sources.
Provider pages establish advertised terms, not independently measured outcomes. General medical guidance does not validate every compounded preparation.
- FDA: Compounding questions and answers (opens in a new tab)
Compounded medicines differ from FDA-approved generic drugs.
- FDA: Managing the benefits and risks of medicines (opens in a new tab)
General questions for evaluating benefit, follow-up and new medicines.
- FDA: Safe drug use after a natural disaster (opens in a new tab)
General temperature-exposure guidance. Does not establish a sermorelin stability window or injectable reconstitution method.
- FDA: Risks of compounded drugs (opens in a new tab)
Explains lack of FDA approval and the risks of poor-quality compounded preparations.
- HHS: Telehealth licensing across state lines (opens in a new tab)
Licensure options depend on the patient location and state rules.
